Cargando…
Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
Rhabdoviruses (RVs) are currently being pursued as anticancer therapeutics for various tumor types, notably leukemia. However, modest virion production and limited spread between noncontiguous circulating leukemic cells requires high-dose administration of RVs, which exceeds the maximum tolerable do...
Autores principales: | Batenchuk, C, Le Boeuf, F, Stubbert, L, Falls, T, Atkins, H L, Bell, J C, Conrad, D P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730201/ https://www.ncbi.nlm.nih.gov/pubmed/23852158 http://dx.doi.org/10.1038/bcj.2013.23 |
Ejemplares similares
-
Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
por: Batenchuk, C, et al.
Publicado: (2014) -
Genetic Relatedness of Dolphin Rhabdovirus with Fish Rhabdoviruses
por: Siegers, Jurre Y., et al.
Publicado: (2014) -
Emerging Rhabdoviruses and Human Infection
por: Shepherd, James G., et al.
Publicado: (2023) -
Immunity to Fish Rhabdoviruses
por: Purcell, Maureen K., et al.
Publicado: (2012) -
Rhabdovirus accessory genes
por: Walker, Peter J., et al.
Publicado: (2011)